A randomized phase III trial of DX-8951f (Exatecan Mesylate; DX) and Gemcitabine (GEM) vs. Gemcitabine alone in advanced pancreatic cancer (APC) Meeting Abstract


Authors: O'Reilly, E. M.; Abou-Alfa, G. K.; Letourneau, R.; Harker, W. G.; Modiano, M.; Hurwitz, H.; Tchekmedyian, N. S.; Ackerman, J.; De Jager, R. L.; Eckhardt, S. G.
Abstract Title: A randomized phase III trial of DX-8951f (Exatecan Mesylate; DX) and Gemcitabine (GEM) vs. Gemcitabine alone in advanced pancreatic cancer (APC)
Meeting Title: 40th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 22
Issue: 14 Suppl.
Meeting Dates: 2004 Jun 5-8
Meeting Location: New Orleans, LA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2004-07-15
Start Page: 315S
Language: English
ACCESSION: WOS:000223512401245
PROVIDER: wos
Notes: Meeting Abstract: 4006 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos
MSK Authors
  1. Ghassan Abou-Alfa
    219 Abou-Alfa
  2. Eileen O'Reilly
    316 O'Reilly
Related MSK Work